Skip to Content

Colesevelam Pregnancy and Breastfeeding Warnings

Colesevelam is also known as: Welchol

Medically reviewed on Jun 18, 2018

Colesevelam Pregnancy Warnings

Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.

Requirements for vitamins and other nutrients are increased during pregnancy, however, the effect of this drug on the absorption of fat-soluble vitamins has not been studied in pregnant women.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

See references

Colesevelam Breastfeeding Warnings

This drug is a nonabsorbable resin and since it does not enter the nursing mother's bloodstream, it will not reach the infant via breast milk.

Use is considered acceptable; according to some experts, caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-This drug is not expected to be excreted into human milk because it is not absorbed systemically from the gastrointestinal tract.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Welchol (colesevelam)" Daiichi Sankyo, Inc., Parsippany, NJ.

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  3. "Product Information. Welchol (colesevelam)" Daiichi Sankyo, Inc., Parsippany, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide